ConductScience.org, home

Paper16624488

Downregulation of leukotriene biosynthesis by thymoquinone attenuates airway inflammation in a mouse model of allergic asthma.

El Gazzar M and 4 others. Biochim Biophys Acta, 2006. Cited by 65 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Downregulation of leukotriene biosynthesis by thymoquinone attenuates airway inflammation in a mouse model of allergic asthma. Papers, record 16624488. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16624488

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Downregulation of leukotriene biosynthesis by thymoquinone attenuates airway inflammation in a mouse model of allergic asthma.
PubMed
Journal
Biochim Biophys Acta
PubMed
Year
2006
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
65
iCite
Relative citation ratio, by iCite
2.04
iCite
Revised in PubMed
2025-05-29
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1El Gazzar MMohamed
2El Mezayen RRabab
3Nicolls MRMark R
4Marecki JCJohn C
5Dreskin SCStephen C

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AsthmaMajor topic
BenzoquinonesMajor topic
Down-RegulationMajor topic
InflammationMajor topic
LeukotrienesMajor topic
Animals
Arachidonate 5-Lipoxygenase
Bronchoalveolar Lavage Fluid
Cytokines
Disease Models, Animal
Female
Hypersensitivity
Lung
Male
Mice
Mice, Inbred BALB C
Nigella sativa

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 HL082662NHLBI NIH HHSUnited StatesR01HL082662PubMed and NIHNIH RePORTER
R01 HL095686NHLBI NIH HHSUnited StatesR01HL095686PubMed and NIHNIH RePORTER
HL 51241NHLBI NIH HHSUnited StatesPubMedPubMed

Download CSV of grants

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.

PMIDTitleJournalYearIn PapersSource
41509113Effects of Nigella sativa and its constituents on total white blood cells count and airway responsiveness value in ovalbumin-induced asthma models: A preclinical systematic review and meta-analysis.Avicenna J Phytomed2025https://conductscience.org/library/papers/41509113PubMed
41018933Thymoquinone Targeting T Helper 2 Cytokines in Animal Models of Asthma: A Systematic Review.Tanaffos2024https://conductscience.org/library/papers/41018933PubMed
40839182Effects of Nigella sativa and its constituents on inflammatory markers in ovalbumin-induced asthma model: a preclinical systematic review and meta-analysis.Inflammopharmacology2025https://conductscience.org/library/papers/40839182PubMed
39464255Inflammation and olfactory loss are associated with at least 139 medical conditions.Front Mol Neurosci2024https://conductscience.org/library/papers/39464255PubMed
38339101Chronic Treatment with Nigella sativa Oil Exerts Antimanic Properties and Reduces Brain Inflammation in Rats.Int J Mol Sci2024https://conductscience.org/library/papers/38339101PubMed
37760822How to Naturally Support the Immune System in Inflammation-Essential Oils as Immune Boosters.Biomedicines2023https://conductscience.org/library/papers/37760822PubMed
36393974Identification of Molecular Markers Related to Immune Infiltration in Patients with Severe Asthma: A Comprehensive Bioinformatics Analysis Based on the Human Bronchial Epithelial Transcriptome.Dis Markers2022https://conductscience.org/library/papers/36393974PubMed
35972596Black Seed (Nigella sativa): A Favourable Alternative Therapy for Inflammatory and Immune System Disorders.Inflammopharmacology2022https://conductscience.org/library/papers/35972596PubMed
34110959Possible therapeutic effects of Nigella sativa and its thymoquinone on COVID-19.Pharm Biol2021https://conductscience.org/library/papers/34110959PubMed
33976534Thymoquinone: A Promising Natural Compound with Potential Benefits for COVID-19 Prevention and Cure.Drug Des Devel Ther2021https://conductscience.org/library/papers/33976534PubMed
33859710Thymoquinone Ameliorates Lung Inflammation and Pathological Changes Observed in Lipopolysaccharide-Induced Lung Injury.Evid Based Complement Alternat Med2021https://conductscience.org/library/papers/33859710PubMed
33047412Revisiting pharmacological potentials of Nigella sativa seed: A promising option for COVID-19 prevention and cure.Phytother Res2021https://conductscience.org/library/papers/33047412PubMed
31143688Clinical and experimental effects of Nigella sativa and its constituents on respiratory and allergic disorders.Avicenna J Phytomed2019https://conductscience.org/library/papers/31143688PubMed
31143211Protective Effects of Thymoquinon on Pulmonary Disorders in Experimental Studies.Tanaffos2018https://conductscience.org/library/papers/31143211PubMed
30166900Medicinal benefits of Nigella sativa in bronchial asthma: A literature review.Saudi Pharm J2017https://conductscience.org/library/papers/30166900PubMed
29629288Natural therapeutic approach of Nigella sativa (Black seed) fixed oil in management of Sinusitis.Integr Med Res2018https://conductscience.org/library/papers/29629288PubMed
27419091The effects of Nigella sativa on neural damage after pentylenetetrazole induced seizures in rats.J Tradit Complement Med2016https://conductscience.org/library/papers/27419091PubMed
25859298Thymoquinone: an emerging natural drug with a wide range of medical applications.Iran J Basic Med Sci2014https://conductscience.org/library/papers/25859298PubMed
25035850The effect of single dose of thymoquinone, the main constituents of Nigella sativa, in guinea pig model of asthma.Bioimpacts2014https://conductscience.org/library/papers/25035850PubMed
23320027Intestinal, airway, and cardiovascular relaxant activities of thymoquinone.Evid Based Complement Alternat Med2012https://conductscience.org/library/papers/23320027PubMed

See all 28 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ALOX5240PubTator's text mininghttps://conductscience.org/library/genes/240

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16624488

GET https://conductscience.org/api/papers/v1/16624488/cited_by?page=2